← Back to directory

Mark J. Caulfield

Researcher Next ID · RN-001582

Researcher · Biochemistry, Genetics and Molecular Biology

Queen Mary University of London

London, United Kingdom

Not currently recruitingFunding unknown
Works count
598
Citation count
117,269
H-index
132
i10-index
348

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Genetic Associations and Epidemiology
Hormonal Regulation and Hypertension
Nutrition, Genetics, and Disease
Genomics and Rare Diseases
Blood Pressure and Hypertension Studies

Publications

  • Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

    The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60685-1

  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

    Nature · 2011 · https://doi.org/10.1038/nature10405

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa0706628

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67185-1

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)12948-0

Current projects

    No projects listed.